Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma

K. Matsuo, K. Takenaka, H. Shimomura, Nobuharu Fujii, K. Shinagawa, Katsuyuki Kiura, M. Harada

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We report a chronic hepatitis B virus (HBV) carrier with non-Hodgkin lymphoma (NHL) who developed HBV hepatitis following conventional dose chemotherapy and was successfully treated with lamivudine and glycyrrhizin. A 55 year-old male patient with primary testicular NHL (diffuse large B-cell type) relapsed. During the salvage chemotherapy, the patient showed elevated serum levels of transaminase and HBV-DNA due to HBV reactivation. Treatment with lamivudine, an antiviral nucleoside analog, was started at a dose of 100mg/day. Shortly after the treatment the HBV-DNA level was suppressed, and sustained elevation of transaminase levels were normalized after additional treatment with glycyrrhizin. This experience suggests that lamivudine combined with glycyrrhizin may be effective for controlling HBV replication and treating chemotherapy-induced HBV hepatitis in chronic HBV carriers with NHL.

Original languageEnglish
Pages (from-to)191-195
Number of pages5
JournalLeukemia and Lymphoma
Volume41
Issue number1-2
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Glycyrrhizic Acid
Lamivudine
Chronic Hepatitis B
Hepatitis B virus
Non-Hodgkin's Lymphoma
Hepatitis
Drug Therapy
Therapeutics
DNA
Virus Replication
Transaminases
Nucleosides
Antiviral Agents
B-Lymphocytes

Keywords

  • Chemotherapy induced hepatitis
  • Glycyrrhizin
  • Hepatitis B carrier
  • Lamivudine
  • Non-Hodgkin lymphoma

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma. / Matsuo, K.; Takenaka, K.; Shimomura, H.; Fujii, Nobuharu; Shinagawa, K.; Kiura, Katsuyuki; Harada, M.

In: Leukemia and Lymphoma, Vol. 41, No. 1-2, 2001, p. 191-195.

Research output: Contribution to journalArticle

@article{b1da41623b734cffb528e912d41bdc87,
title = "Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma",
abstract = "We report a chronic hepatitis B virus (HBV) carrier with non-Hodgkin lymphoma (NHL) who developed HBV hepatitis following conventional dose chemotherapy and was successfully treated with lamivudine and glycyrrhizin. A 55 year-old male patient with primary testicular NHL (diffuse large B-cell type) relapsed. During the salvage chemotherapy, the patient showed elevated serum levels of transaminase and HBV-DNA due to HBV reactivation. Treatment with lamivudine, an antiviral nucleoside analog, was started at a dose of 100mg/day. Shortly after the treatment the HBV-DNA level was suppressed, and sustained elevation of transaminase levels were normalized after additional treatment with glycyrrhizin. This experience suggests that lamivudine combined with glycyrrhizin may be effective for controlling HBV replication and treating chemotherapy-induced HBV hepatitis in chronic HBV carriers with NHL.",
keywords = "Chemotherapy induced hepatitis, Glycyrrhizin, Hepatitis B carrier, Lamivudine, Non-Hodgkin lymphoma",
author = "K. Matsuo and K. Takenaka and H. Shimomura and Nobuharu Fujii and K. Shinagawa and Katsuyuki Kiura and M. Harada",
year = "2001",
language = "English",
volume = "41",
pages = "191--195",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "1-2",

}

TY - JOUR

T1 - Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma

AU - Matsuo, K.

AU - Takenaka, K.

AU - Shimomura, H.

AU - Fujii, Nobuharu

AU - Shinagawa, K.

AU - Kiura, Katsuyuki

AU - Harada, M.

PY - 2001

Y1 - 2001

N2 - We report a chronic hepatitis B virus (HBV) carrier with non-Hodgkin lymphoma (NHL) who developed HBV hepatitis following conventional dose chemotherapy and was successfully treated with lamivudine and glycyrrhizin. A 55 year-old male patient with primary testicular NHL (diffuse large B-cell type) relapsed. During the salvage chemotherapy, the patient showed elevated serum levels of transaminase and HBV-DNA due to HBV reactivation. Treatment with lamivudine, an antiviral nucleoside analog, was started at a dose of 100mg/day. Shortly after the treatment the HBV-DNA level was suppressed, and sustained elevation of transaminase levels were normalized after additional treatment with glycyrrhizin. This experience suggests that lamivudine combined with glycyrrhizin may be effective for controlling HBV replication and treating chemotherapy-induced HBV hepatitis in chronic HBV carriers with NHL.

AB - We report a chronic hepatitis B virus (HBV) carrier with non-Hodgkin lymphoma (NHL) who developed HBV hepatitis following conventional dose chemotherapy and was successfully treated with lamivudine and glycyrrhizin. A 55 year-old male patient with primary testicular NHL (diffuse large B-cell type) relapsed. During the salvage chemotherapy, the patient showed elevated serum levels of transaminase and HBV-DNA due to HBV reactivation. Treatment with lamivudine, an antiviral nucleoside analog, was started at a dose of 100mg/day. Shortly after the treatment the HBV-DNA level was suppressed, and sustained elevation of transaminase levels were normalized after additional treatment with glycyrrhizin. This experience suggests that lamivudine combined with glycyrrhizin may be effective for controlling HBV replication and treating chemotherapy-induced HBV hepatitis in chronic HBV carriers with NHL.

KW - Chemotherapy induced hepatitis

KW - Glycyrrhizin

KW - Hepatitis B carrier

KW - Lamivudine

KW - Non-Hodgkin lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0035066646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035066646&partnerID=8YFLogxK

M3 - Article

C2 - 11342373

AN - SCOPUS:0035066646

VL - 41

SP - 191

EP - 195

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 1-2

ER -